(Q42241925)

19 October 2017

Ocular toxicity of high-dose intravenous desferrioxamine (English)

1 reference

19 October 2017

0 references

5

G. B. Arden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135026

12 August 2023

author name string

S. C. Davies

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135026

12 August 2023

R. E. Marcus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135026

12 August 2023

J. L. Hungerford

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135026

12 August 2023

M. H. Miller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135026

12 August 2023

E. R. Huehns

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6135026

12 August 2023

language of work or name

English

0 references

publication date

1 July 1983

1 reference

19 October 2017

23 July 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6135026

full work available at URL

12 August 2023

https://api.elsevier.com/content/article/PII:S0140673683901708?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)90170-8

https://api.elsevier.com/content/article/PII:S0140673683901708?httpAccept=text/plain

12 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)90170-8

12 August 2023

1 reference

19 October 2017

2

1 reference

19 October 2017

181-184

1 reference

19 October 2017

8343

1 reference

Rapid desensitisation for desferrioxamine anaphylactic reaction

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990170-8

7 January 2021

Reassessment of the Use of Desferrioxamine B in Iron Overload

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990170-8

7 January 2021

Continuous subcutaenous administration of deferoxamine in patients with iron overload

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990170-8

7 January 2021

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990170-8

7 January 2021

Copper metabolism in retinitis pigmentosa patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990170-8

7 January 2021

Treatment of Experimental Siderosis Bulbi, Vitreous Hemorrhage, and Corneal Bloodstaining With Deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990170-8

7 January 2021

Lens opacities in thalassemia

1

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)90170-8

Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine

12 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)90170-8

Copper metabolism changes in pigmentary retinopathies and high myopia

12 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)90170-8

12 August 2023

Identifiers

1 reference

19 October 2017

1 reference